krystal-1: adagrasib with cetuximab in kras g12c-mutated crc
Published 5 months ago • 124 plays • Length 1:01Download video MP4
Download video MP3
Similar videos
-
2:51
#esmo21 highlights on adagrasib in patients with krasg12c-mutated crc: the krystal-1 study
-
3:48
krystal-1: adagrasib as monotherapy or combined with cetuximab in patients with crc harboring a ...
-
2:54
krystal-1: adagrasib for kras-mutant nsclc
-
1:00
krystal-1: next steps in the field of krasg12c-mutant cancers
-
1:26
krystal-1 and codebreak 100: targeting kras g12c in lung cancer
-
3:17
krystal-1: activity of adagrasib in krasg12m nsclc with untreated cns metastases
-
1:22
krystal-1: activity and safety of adagrasib in patients with advanced/metastatic krasg12cm nsclc
-
1:10
current treatment strategies krasg12c–mutated nsclc
-
1:08
how will adagrasib fit into the treatment landscape of krasg12-mutant nsclc?
-
0:58
kras g12c inhibitors for gi cancer
-
1:18
krystal-1: adagrasib in nsclc patients with cns metastases
-
1:12
overcoming resistance to kras g12c inhibitors in nsclc
-
2:40
krystal 7 study: adagrasib /- pembrolizumab for kras g12c nsclc -targeted therapies in lung cancer
-
5:26
asco 2021 lung recap: codebreak 100: sotorasib in kras g12c mutation
-
4:13
sotorasib vs. adagrasib as treatment for kras g12c mutated nsclc - case based panel discussion
-
1:17
codebreak100: assessing sotorasib in patients with kras p.g12c-mutant pancreatic cancer
-
7:19
safety of sotorasib and panitumumab in advanced kras p.g12c-mutated colorectal cancer
-
12:25
adagrasib for previously treated kras g12c nsclc - asco lung review 2022
-
1:19
ly3537982: a novel kras g12c inhibitor in solid tumors